Long Term Debt - Corcept Therapeutics Inc (NASDAQ:CORT) - Alpha Spread

Corcept Therapeutics Inc
NASDAQ:CORT

Watchlist Manager
Corcept Therapeutics Inc Logo
Corcept Therapeutics Inc
NASDAQ:CORT
Watchlist
Price: 43.93 USD 1.5% Market Closed
Market Cap: 4.8B USD
Have any thoughts about
Corcept Therapeutics Inc?
Write Note

Corcept Therapeutics Inc
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Corcept Therapeutics Inc
Long-Term Debt Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Corcept Therapeutics Inc
NASDAQ:CORT
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Long-Term Debt
$31.6B
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
9%
Bristol-Myers Squibb Co
NYSE:BMY
Long-Term Debt
$48.9B
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
21%
Pfizer Inc
NYSE:PFE
Long-Term Debt
$57.5B
CAGR 3-Years
18%
CAGR 5-Years
10%
CAGR 10-Years
6%
Merck & Co Inc
NYSE:MRK
Long-Term Debt
$34.7B
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
Long-Term Debt
$23.7B
CAGR 3-Years
17%
CAGR 5-Years
12%
CAGR 10-Years
16%

See Also

What is Corcept Therapeutics Inc's Long-Term Debt?
Long-Term Debt
0 USD

Based on the financial report for Jun 30, 2024, Corcept Therapeutics Inc's Long-Term Debt amounts to 0 USD.

Back to Top